Diane Major

2.0k total citations
42 papers, 1.5k citations indexed

About

Diane Major is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Diane Major has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 12 papers in Immunology and 11 papers in Infectious Diseases. Recurrent topics in Diane Major's work include Influenza Virus Research Studies (38 papers), Respiratory viral infections research (14 papers) and Animal Disease Management and Epidemiology (10 papers). Diane Major is often cited by papers focused on Influenza Virus Research Studies (38 papers), Respiratory viral infections research (14 papers) and Animal Disease Management and Epidemiology (10 papers). Diane Major collaborates with scholars based in United Kingdom, Norway and United States. Diane Major's co-authors include John Wood, James S. Robertson, Carolyn Nicolson, Robert W. Newman, Maria Zambon, Katja Höschler, Rebecca Jane Cox, Jacqueline M. Katz, Janet S. Bootman and Abdullah S. Madhun and has published in prestigious journals such as PLoS ONE, Biomaterials and Emerging infectious diseases.

In The Last Decade

Diane Major

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Major United Kingdom 24 1.3k 497 408 328 278 42 1.5k
Robert G. Webster United States 15 1.3k 1.0× 517 1.0× 344 0.8× 400 1.2× 581 2.1× 16 1.7k
Bert E. Johansson United States 24 1.6k 1.2× 360 0.7× 473 1.2× 327 1.0× 286 1.0× 39 1.8k
K. Nerome Japan 22 1.2k 0.9× 351 0.7× 243 0.6× 377 1.1× 309 1.1× 61 1.5k
Irina Margine United States 20 1.9k 1.5× 545 1.1× 899 2.2× 365 1.1× 298 1.1× 20 2.2k
Amorsolo L. Suguitan United States 21 1.8k 1.4× 668 1.3× 781 1.9× 258 0.8× 548 2.0× 27 2.2k
Corey J. Crevar United States 17 1.0k 0.8× 351 0.7× 422 1.0× 231 0.7× 216 0.8× 24 1.2k
Julia A. Misplon United States 17 1.5k 1.2× 393 0.8× 1.0k 2.6× 263 0.8× 168 0.6× 32 1.8k
Aleksandr S. Lipatov United States 21 1.7k 1.3× 704 1.4× 560 1.4× 294 0.9× 745 2.7× 25 2.0k
Janet S. Bootman United Kingdom 15 705 0.5× 360 0.7× 309 0.8× 279 0.9× 113 0.4× 22 1.2k
Larisa Rudenko Russia 25 1.9k 1.5× 804 1.6× 659 1.6× 341 1.0× 367 1.3× 166 2.2k

Countries citing papers authored by Diane Major

Since Specialization
Citations

This map shows the geographic impact of Diane Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Major more than expected).

Fields of papers citing papers by Diane Major

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Major. The network helps show where Diane Major may publish in the future.

Co-authorship network of co-authors of Diane Major

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Major. A scholar is included among the top collaborators of Diane Major based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Major. Diane Major is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guilfoyle, Kate, Diane Major, Heather James, et al.. (2020). Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model. Vaccine. 39(34). 4903–4913. 11 indexed citations
2.
Major, Diane, Jessica A. Chichester, Rishi D. Pathirana, et al.. (2015). Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. Human Vaccines & Immunotherapeutics. 11(5). 0–0. 23 indexed citations
3.
Cox, Rebecca Jane, Diane Major, Gabriel Kristian Pedersen, et al.. (2015). Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets. PLoS ONE. 10(7). e0131652–e0131652. 12 indexed citations
4.
Campion, K, et al.. (2014). Healthcare workers' attitude towards influenza vaccination after the 2009 pandemic. Occupational Medicine. 64(5). 348–351. 12 indexed citations
5.
Pedersen, Gabriel Kristian, et al.. (2011). Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model. Influenza and Other Respiratory Viruses. 5(6). 426–437. 38 indexed citations
6.
Wood, John, Diane Major, Alan Heath, et al.. (2011). Reproducibility of serology assays for pandemic influenza H1N1: Collaborative study to evaluate a candidate WHO International Standard. Vaccine. 30(2). 210–217. 61 indexed citations
7.
Harvey, Ruth, Carolyn Nicolson, Rachel Johnson, et al.. (2010). Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine. 28(50). 8008–8014. 28 indexed citations
8.
Hovden, Arnt‐Ove, Karl A. Brokstad, Diane Major, et al.. (2009). A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice. Influenza and Other Respiratory Viruses. 3(1). 21–28. 7 indexed citations
9.
Cox, Rebecca Jane, Diane Major, Abdullah S. Madhun, et al.. (2009). A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. Influenza and Other Respiratory Viruses. 3(3). 107–117. 29 indexed citations
10.
Cox, Rebecca Jane, Abdullah S. Madhun, Haakon Sjursen, et al.. (2009). A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine. Vaccine. 27(13). 1889–1897. 122 indexed citations
11.
Nicolson, Carolyn, Diane Major, John Wood, & James S. Robertson. (2004). Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine. 23(22). 2943–2952. 133 indexed citations
12.
Wood, John, K. G. Nicholson, Iain Stephenson, et al.. (2002). Experience with the clinical development of influenza vaccines for potential pandemics. Medical Microbiology and Immunology. 191(3). 197–201. 7 indexed citations
13.
Wood, John, Diane Major, Robert W. Newman, et al.. (2002). Preparation of vaccines against H5N1 influenza. Vaccine. 20. S84–S87. 12 indexed citations
14.
Jabbal‐Gill, Inderjit, Lin Wu, Peter Watts, et al.. (1999). Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines. Vaccine. 18(3-4). 238–250. 41 indexed citations
15.
Coombes, A.G.A., Diane Major, John Wood, et al.. (1998). Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines. Biomaterials. 19(11-12). 1073–1081. 23 indexed citations
16.
Gubareva, Larisa V., John Wood, William J. Meyer, et al.. (1994). Codominant Mixtures of Viruses in Reference Strains of Influenza Virus Due to Host Cell Variation. Virology. 199(1). 89–97. 37 indexed citations
17.
18.
Wood, John, et al.. (1993). Influence of Host Cell-Mediated Variation on the International Surveillance of Influenza A (H3N2) Viruses. Virology. 196(1). 130–137. 60 indexed citations
19.
Robertson, James S., et al.. (1991). Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. Journal of General Virology. 72(11). 2671–2677. 62 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert G. Webster Breakdown of academic impact, for papers by Bert E. Johansson Breakdown of academic impact, for papers by K. Nerome Breakdown of academic impact, for papers by Irina Margine Breakdown of academic impact, for papers by Amorsolo L. Suguitan Breakdown of academic impact, for papers by Corey J. Crevar Breakdown of academic impact, for papers by Julia A. Misplon Breakdown of academic impact, for papers by Aleksandr S. Lipatov Breakdown of academic impact, for papers by Janet S. Bootman Breakdown of academic impact, for papers by Larisa Rudenko
Rankless by CCL
2026